Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03607994 · ClinicalTrials.gov registry record · NA
Study of the Effects of HIRREM-SOP for Insomnia
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03607994 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 22 participants.
The verdict
NCT03607994, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Prior research studies have shown benefit for use of a technique called High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM®), to reduce symptoms of moderate to severe insomnia. HIRREM uses scalp sensors to monitor brain electrical activity, and software algorithms translate selected brain frequencies into audible tones in real time. Those tones (acoustic stimulation) are reflected back to participants via ear buds in as little as four milliseconds, providing the brain an opportunity to self-adjust and balance its electrical pattern. The purpose of this research study is to determine the effects of HIRREM-SOP, an updated version of this technology that is based on the HIRREM approach, but now includes new hardware and software, a standardized series of HIRREM protocols, and a fixed number of sessions. Adults over the age of 18 who have documented sleep trouble that place them in the category of subthreshold (mild), moderate, or severe clinical insomnia as defined by the Insomnia Severity Index, are eligible to participate in the study.
Interventions
- DEVICE HIRREM-SOP
- DEVICE NCC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2018-11-19 |
| Est. Completion | 2020-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03607994
The ClinicalTrials.gov registry entry for NCT03607994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HIRREM-SOP is the first listed.
NCT03607994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03607994 about?
NCT03607994 is a clinical study titled "Study of the Effects of HIRREM-SOP for Insomnia". Prior research studies have shown benefit for use of a technique called High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM®), to reduce symptoms of moderate to severe insomnia. HIRREM uses scalp sensors to monitor brain electrical activity, and software algorithms tran...
What is the current status of trial NCT03607994?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2018-11-19. Estimated completion is 2020-07-30.
What interventions are being tested in trial NCT03607994?
The interventions under investigation include: HIRREM-SOP (DEVICE), NCC (DEVICE).
Who is sponsoring clinical trial NCT03607994?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.